期刊
JOURNAL OF NEURAL TRANSMISSION
卷 125, 期 8, 页码 1195-1202出版社
SPRINGER WIEN
DOI: 10.1007/s00702-018-1865-5
关键词
Parkinson's disease; Dyskinesia; Serotonin; Serotonin autoreceptors; L-DOPA
资金
- Michael J Fox Foundation
- Parkinson's Disease Foundation
- Italian Ministry of Education, Universities and Research, Progetto di Ricerca di Interesse Nazionale (PRIN) [2010-AHHP5H]
- Swedish Research Council [04X-3824]
During the last decade, the serotonergic system has emerged as a key player in the appearance of L-DOPA-induced dyskinesia in animal models of Parkinson's disease. Clinical investigations, based on imaging and postmortem analyses, suggest that the serotonin neurons are also involved in the etiology of this complication of long-term L-DOPA treatment in parkinsonian patients. These findings have stimulated efforts to develop new therapies using drugs targeting the malfunctioning serotonin neurons. In this review, we summarize the experimental and clinical data obtained so far and discuss the prospects for further development of this therapeutic strategy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据